Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Lloyd Inc. of Iowa
WARNING LETTER
•Lloyd Inc. of Iowa•April 16, 2013

Lloyd Inc. of Iowa – FDA Warning Letter, Apr 16, 2013

Record Details

An FDA inspection of Lloyd Inc. of Iowa from March 18 to April 16, 2013, revealed significant Current Good Manufacturing Practice (CGMP) violations for Finished Pharmaceuticals (21 CFR Parts 210 and 211) in their animal drug manufacturing, rendering products adulterated under section 501(a)(2)(B) of the Act. Key deficiencies included failure to justify component overages in master production records for Levothyroxine products, lack of process validation studies for all strengths, and inconsistent in-process and final specifications. The firm also failed to ensure representative in-process sampling. Critical quality system failures involved inadequate complaint handling, with numerous consumer complaints uninvestigated, and the Quality Control Unit failing to conduct or document necessary investigations (21 CFR §§ 211.198(a), 211.198(b)(3)). Furthermore, the firm did not thoroughly investigate unexplained discrepancies like recalled lots, OOS reports, and stability failures (21 CFR § 211.192), nor did it complete required annual product reviews (21 CFR § 211.180(e)). The FDA highlighted a decade of repeated quality system deficiencies, indicating a lack of sustainable corrective actions. The firm recalled affected Levothyroxine lots and plans to cease manufacturing certain products. The FDA deemed the firm's responses insufficient, demanding a comprehensive written response within 15 working days detailing specific, documented corrective actions and a timetable to prevent enforcement actions such as seizure or injunction.

Company
Lloyd Inc. of Iowa
Inspection date
April 16, 2013
Product type
Drugs
Office
Kansas City District Office
Person
  • John W. Thorsky (District Director)
View Company Profile

ID · fd6bfcd6-78bb-4b8c-8444-271e85cb6d42

Violation Codes4
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Lloyd Inc. of Iowa
  • 483 - 2025-11-06November 6, 2025
  • 483 - 2023-09-15September 15, 2023
  • 483 - 2018-02-02February 2, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lloyd Inc. of Iowa
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.